WHO ICTRP trial
A phase III, open, controlled study to assess the safety, reactogenicity and…
EUCTR2006-005733-38-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2006-005733-38-DE |
|---|---|
| Public title | A phase III, open, controlled study to assess the safety, reactogenicity and immunogenicity of GlaxoSmithKline (GSK) Biologicals’ 10-valent pneumococcal conjugate vaccine or Prevenar when given as a booster dose between 11-18 months of age in children previously vaccinated in the primary study 10PN-PD-DIT-011 (107005) with either GSK Biologicals’ 10-valent pneumococcal conjugate vaccine or Prevenar. - 10PN-PD-DIT-017 BST 011 |
| Scientific title | A phase III, open, controlled study to assess the safety, reactogenicity and immunogenicity of GlaxoSmithKline (GSK) Biologicals’ 10-valent pneumococcal conjugate vaccine or Prevenar when given as a booster dose between 11-18 months of age in children previously vaccinated in the primary study… |
| Primary sponsor | GlaxoSmithKline Biologicals |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Germany;Spain;Poland |
| Conditions | Booster vaccination against Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae type b in healthy infants 11 to18 months of age who were previously primed with three doses of pneumococcal conjugate vaccine… |
| Interventions | Product Name: 10-valent Streptococcus pneumoniae conjugate vaccine Product Code: 10Pn-PD-DiT Pharmaceutical Form: Suspension for injection Concentration unit: µg/ml microgram(s)/millilitre Concentration type: equal Concentration number… |
| Registration date | Jan 2, 2007 |
| Target size | 800 |
| Secondary IDs | 109507 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: